Atlas Trials

Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination

Clinical trial NCT06007183 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06007183
Sponsor
Bavarian Nordic
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Chikungunya Virus Infection
Start date
2023-08-30
Primary completion
2028-02-01
Enrollment
715

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.